- Home
- AVNS vs RLAY Comparison
AVNS vs RLAY Comparison
Compare AVNS & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- RLAY
- Stock Information
- Founded
- AVNS 2014
- RLAY 2015
- Country
- AVNS United States
- RLAY United States
- Employees
- AVNS N/A
- RLAY N/A
- Industry
- AVNS Industrial Specialties
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVNS Health Care
- RLAY Health Care
- Exchange
- AVNS Nasdaq
- RLAY Nasdaq
- Market Cap
- AVNS 591.9M
- RLAY 610.3M
- IPO Year
- AVNS N/A
- RLAY 2020
- Fundamental
- Price
- AVNS $11.70
- RLAY $3.69
- Analyst Decision
- AVNS
- RLAY Strong Buy
- Analyst Count
- AVNS 0
- RLAY 12
- Target Price
- AVNS N/A
- RLAY $18.45
- AVG Volume (30 Days)
- AVNS 785.5K
- RLAY 2.0M
- Earning Date
- AVNS 08-05-2025
- RLAY 08-07-2025
- Dividend Yield
- AVNS N/A
- RLAY N/A
- EPS Growth
- AVNS N/A
- RLAY N/A
- EPS
- AVNS N/A
- RLAY N/A
- Revenue
- AVNS $692,500,000.00
- RLAY $8,355,000.00
- Revenue This Year
- AVNS N/A
- RLAY $31.55
- Revenue Next Year
- AVNS $3.42
- RLAY N/A
- P/E Ratio
- AVNS N/A
- RLAY N/A
- Revenue Growth
- AVNS 1.48
- RLAY N/A
- 52 Week Low
- AVNS $9.30
- RLAY $1.78
- 52 Week High
- AVNS $25.36
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- AVNS 55.78
- RLAY 58.31
- Support Level
- AVNS $11.12
- RLAY $3.31
- Resistance Level
- AVNS $11.57
- RLAY $3.65
- Average True Range (ATR)
- AVNS 0.58
- RLAY 0.18
- MACD
- AVNS 0.12
- RLAY 0.01
- Stochastic Oscillator
- AVNS 99.17
- RLAY 93.01
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).